TNF and Lymphotoxin-α Polymorphisms Associated with Common Variable Immunodeficiency: Role in the Pathogenesis of Granulomatous Disease

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6236-6241

  Mullighan, Charles G ^a   Fanning, Gregory C ^a   Chapel, Helen M ^a   Welsh, Kenneth I ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031573549     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cunningham Rundles, C. 1989. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J. Clin. Immunol. 9:22.
2. Sneller, M. C., W. Strober, E. Eisenstein, J. S. Jaffe, and C. Cunningham Rundles. 1993. NIH conference: new insights into common variable immunodeficiency. Ann. Intern. Med. 118:720.
3. WHO. 1995. Primary immunodeficiency diseases: report of a WHO scientific group. Clin. Exp. Immunol. 1:1.
4. Bryant, A., N. C. Calver, E. Toubi, A. D. Webster, and J. Farrant. 1990. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin. Immunol. Immunopathol. 56:239.
5. Wright, J. J., D. K. Wagner, R. M. Blaese, C. Hagengruber, T. A. Waldmann, and T. A. Fleisher. 1990. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 76:2046.
6. Fasano, M. B., K. E. Sullivan, S. B. Sarpong, R. A. Wood, S. M. Jones, C. J. Johns, H. M. Lederman, M. J. Bykowsky, J. M. Greene, and J. A. Winkelstein. 1996. Sarcoidosis and common variable immunodeficiency: report of 8 cases and review of the literature. Medicine 75:251.
7. Aukrust, P., E. Lien, A. K. Kristoffersen, F. Muller, C. J. Haug, T. Espevik, and S. S. Froland. 1996. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency: possible immunologic and clinical consequences. Blood 87:674.
8. James, D. G. 1992. Mimics of sarcoidosis: granulomatous hypogammaglobulinaemia. Sarcoidosis 9:1.
9. Spickett, G. P., A. D. Webster, and J. Farrant. 1990. Cellular abnormalities in common variable immunodeficiency. Immunodefic. Rev. 2:199.
10. + T lymphocyte subsets in patients with common variable immunodeficiency. Clin. Immunol. Immunopathol. 61:83.
11. Farrant, J., G. Spickett, N. Matamoros, D. Copas, M. Hernandez, M. North, H. Chapel, and A. D. Webster. 1994. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID). Immunodeficiency 5:159.
12. Reinherz, E. L., M. D. Cooper, and S. F. Schlossman. 1981. Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. J. Clin. Invest. 68:699.
13. Baumert, E., G. Wolff Vorbeck, M. Schlesier, and H. H. Peter. 1992. Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin. Exp. Immunol. 90:25.
14. + lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress. Blood 86:1383.
15. Friedman, J. M., P. J. Kialkow, S. D. Davis, H. D. Ochs, and R. J. Wedgwood. 1977. Autoimmunity in the relatives of patients with immunodeficiency diseases. Clin. Exp. Immunol. 28:375.
16. Vorechovsky, I., J. Litzman, J. Lokaj, and R. Sobotkova. 1991. Family studies in common variable immunodeficiency. J. Hyg. Epidemiol. Microbiol. Immunol. 35:17.
17. Schaffer, F. M., J. Palermos, Z. B. Zhu, B. O. Barger, M. D. Cooper, and J. E. Volanakis. 1989. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc. Natl. Acad. Sci. USA 86:8015.
18. Howe, H. S., A. K. So, J. Farrant, and A. D. Webster. 1991. Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex. Clin. Exp. Immunol. 83:387.
19. Volanakis, J. E., Z. B. Zhu, F. M. Schaffer, K. J. Macon, J. Palermos, B. O. Barger, R. Go, R. D. Campbell, H. W. Schroeder, Jr., and M. D. Cooper. 1992. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J. Clin. Invest. 89:1914.
20. Olerup, O., C. I. Smith, J. Bjorkander, and L. Hammarstrom. 1992. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc. Natl. Acad. Sci. USA 89:10653.
21. Mullighan, C. G., K. I. Welsh, and A. G. Bird. 1995. HLA associations of common variable immunodeficiency. Immunology 86:56 (Abstr.).
22. Beutler, B., and A. Cerami. 1989. The biology of cachexin/TNF: a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
23. Ruddle, N. H. 1992. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr. Opin. Immunol. 4:327.
24. Aguado, B., C. M. Milner, and R. D. Campbell. 1996. Genes of the MHC class III region and the functions of the proteins they encode. In HLA and MHC: Genes, Molecules and Function. M. J. Browning and A. J. McMichael, eds. BIOS Scientific Publishers Ltd., Oxford, pp. 39-75.
25. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centres, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.
26. Myatt, N., G. Coghill, K. Morrison, D. Jones, and I. A. Cree. 1994. Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation. J. Clin. Pathol. 47:423.
27. Joseph, A. L., and D. L. Boros. 1993. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J. Immunol. 151:5461.
28. Douni, E., K. Akassoglou, L. Alexopoulou, S. Georgolpouolos, S. Haralambous, S. Hill, G. Kassiotis, D. Kontoyiannis, M. Pasparakis, D. Plows, L. Probert, and G. Kollias. 1995. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J. Inflamm. 45:27.
29. Paul, N. L., and N. H. Ruddle. 1988. Lymphotoxin. Annu. Rev. Immunol. 6:407.
30. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centres. Science 271:1289.
31. De-Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Pick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, and J. Strauss-Schoenberger. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
32. Dunham, I., C. A. Sargent, J. Trowsdale, and R. D. Campbell. 1987. Molecular mapping of the major histocompatibility complex by pulse-field gel electrophoresis. Proc. Natl. Acad. Sci. USA 84:7237.
33. Carroll, M. C., P. Katzmann, and E. M. Alicot. 1987. Linkage map of the human major histocompatibility complex including he tumour necrosis factor genes. Proc. Natl. Acad. Sci. USA 84:8535.
34. Fanning, G. C., M. Bunce, C. M. Black, and K. I. Welsh. 1997. PCR-haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumour necrosis factor and lymphotoxin alpha. Tissue Antigens. 50:23.
35. Westendorp, R. G., J. A. M. Langermans, T. W. J. Huizinga, A. H. Elouali, C. L. Verweij, D. I. Poomsma, and J. P. Vandenbrouke. 1997. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170.
36. Bouma, G., J. B. Crusius, M. Oudkerk Pool, J. J. Kolkman, B. M. von Blomberg, P. J. Kostense, M. J. Giphart, G. M. Schreuder, S. G. Meuwissen, and A. S. Pena. 1996. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand. J. Immunol. 43:456.
37. Messer, G., U. Spengler, M. C. Jung, G. Honold, K. Blomer, G. R. Pape, G. Riethmuller, and E. H. Weiss. 1991. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J. Exp. Med. 173:209.
38. Pociot, F., J. Molvig, L. Wogensen, H. Worsaae, H. Dalboge, L. Baek, and J. Nerup. 1991. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand. J. Immunol. 33:37.
39. Wilson, A. G., F. S. di Giovine, and G. W. Duff. 1995. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J. Inflamm. 45:1.
40. Healey, C. J., N. K. Sabharwal, J. Daub, F. Davidson, P. L. Yap, K. A. Fleming, R. W. Chapman, P. Simmonds, and H. Chapel. 1996. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus screened intravenous immunoglobulin therapy. Gastroenterology 110:1120.
41. Bunce, M., M. C. N. M. Barnardo, J. Procter, S. G. E. Marsh, C. Vilches, and K. I. Welsh. 1996. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibrium in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 48:680.
42. Bunce, M., C. M. O'Neill, M. C. N. M. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46:355.
43. Wilson, A. G., N. de Vries, F. Pociot, F. S. di Giovine, L. B. van der Putte, and G. W. Duff. 1993. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J. Exp. Med. 177:557.
44. Svejgaard, A., and L. P. Ryder. 1994. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994:18.
45. Aukrust, P., F. Muller, and S. S. Froland. 1994. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin. Exp. Immunol. 97:232.
46. D'Alfonso, S. M. P. 1996. A new polymorphism in the TNFA gene. Hum. Immunol. 47:65 (Abstr.).
47. Spickett, G. P., J. G. Zhang, T. Green, and J. Shrimankar. 1996. Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy. J. Clin. Pathol. 49:431.
48. McGuire, W., A. V. Hill, C. E. Allsopp, B. M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508.